-
-
-
-
-
-
-
Mereo BioPharma (MREO) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c
-
-
-
-
-
-
-
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) and Mereo BioPharma (MREO) Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab Significantly Reduced Fracture Rates in Patients with OI
-
-
-
-
-
-
-
Mereo BioPharma to Present at the Jefferies Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conference
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

